Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2023 |
|---|---|
| Revenue | 58,836 |
| EBITDA | 5,506 |
| Net profit | 2,843 |
| Total assets | 48,567 |
| n (companies reporting) | 5 |
GEL, thousands
| Company | FY 2023 |
|---|---|
| Endokrinologiis Erovnul… | 14,193 |
| Curatio | 13,274 |
| Med Investment | 11,967 |
| Reimani | 7,773 |
| Adiktologiis Regionalur… | 11,629 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.